Abstract
Background
Conflicting findings have been reported on the prognostic significance of serum 25-hydroxyvitamin D level in patients with stroke. The objective of this meta-analysis was to evaluate the prognostic utility of serum 25-hydroxyvitamin D in stroke patients.
Methods
PubMed and Embase databases were systematically searched for potentially eligible studies until October 16, 2019. Observational studies investigating the association between serum 25-hydroxyvitamin D level and prognosis of patients with stroke were eligible. Multivariable adjusted risk ratios (RR) with 95% confidence intervals (CI) of poor functional outcome, all-cause mortality, and recurrence of stroke were pooled with the lowest versus the highest category of 25-hydroxyvitamin D level.
Results
Eleven articles (ten studies) involving 6845 stroke patients satisfied our predefined inclusion criteria. Lower serum 25-hydroxyvitamin D level was associated with an increased risk of poor functional outcome (RR 1.86; 95% CI 1.16–2.98), all-cause mortality (RR 3.56; 95% CI 1.54–8.25), and recurrence of stroke (RR 5.49; 95% CI 2.69–11.23). Sensitivity analysis further confirmed the above findings.
Conclusions
Lower serum 25-hydroxyvitamin D level is significantly associated with poorer prognosis in stroke patients. Future prospective studies are warranted to verify the prognostic role and to examine the association in different subtypes of stroke.
Similar content being viewed by others
References
Apostolakis M, Armeni E, Bakas P, Lambrinoudaki I (2018) Vitamin D and cardiovascular disease. Maturitas 115:1–22
Calton EK, Keane KN, Newsholme P, Soares MJ (2015) The impact of vitamin D levels on inflammatory status: a systematic review of immune cell studies. PLoS One 10:e0141770
Daubail B, Jacquin A, Guilland JC, Khoumri C, Aboa-Eboule C, Giroud M, Bejot Y (2014) Association between serum concentration of vitamin D and 1-year mortality in stroke patients. Cerebrovasc Dis 37:364–367
Daubail B, Jacquin A, Guilland JC, Hervieu M, Osseby GV, Rouaud O, Giroud M, Bejot Y (2013) Serum 25-hydroxyvitamin D predicts severity and prognosis in stroke patients. Eur J Neurol 20:57–61
Daumas A, Daubail B, Legris N, Jacquin-Piques A, Sensenbrenner B, Denimal D, Lemaire-Ewing S, Duvillard L, Giroud M, Bejot Y (2016) Association between admission serum 25-hydroxyvitamin D levels and functional outcome of thrombolyzed stroke patients. J Stroke Cerebrovasc Dis 25:907–913
Ferrucci L, Giallauria F, Guralnik JM (2008) Epidemiology of aging. Radiol Clin N Am 46(643–652):v
Heaney RP (2004) Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr 80:1706S–1709S
Huang H, Zheng T, Wang S, Wei L, Wang Q, Sun Z (2016) Serum 25-hydroxyvitamin D predicts early recurrent stroke in ischemic stroke patients. Nutr Metab Cardiovasc Dis 26:908–914
Jackson JL, Judd SE, Panwar B, Howard VJ, Wadley VG, Jenny NS, Gutierrez OM (2016) Associations of 25-hydroxyvitamin D with markers of inflammation, insulin resistance and obesity in black and white community-dwelling adults. J Clin Transl Endocrinol 5:21–25
Ji W, Zhou H, Wang S, Cheng L, Fang Y (2017) Low serum levels of 25-hydroxyvitamin D are associated with stroke recurrence and poor functional outcomes in patients with ischemic stroke. J Nutr Health Aging 21:892–896
Kim K, Cho KH, Im SH, Choi J, Yu J, Kim M (2017) Decrement of serum vitamin D level after stroke. Ann Rehabil Med 41:944–950
Laird E, McNulty H, Ward M, Hoey L, McSorley E, Wallace JM, Carson E, Molloy AM, Healy M, Casey MC, Cunningham C, Strain JJ (2014) Vitamin D deficiency is associated with inflammation in older Irish adults. J Clin Endocrinol Metab 99:1807–1815
Lau J, Ioannidis JP, Terrin N, Schmid CH, Olkin I (2006) The case of the misleading funnel plot. BMJ 333:597–600
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62:e1–e34
Mao PJ, Zhang C, Tang L, Xian YQ, Li YS, Wang WD, Zhu XH, Qiu HL, He J, Zhou YH (2013) Effect of calcium or vitamin D supplementation on vascular outcomes: a meta-analysis of randomized controlled trials. Int J Cardiol 169:106–111
Murray CJ, Lopez AD (2013) Measuring the global burden of disease. N Engl J Med 369:448–457
Ng GJL, Quek AML, Cheung C, Arumugam TV, Seet RCS (2017) Stroke biomarkers in clinical practice: a critical appraisal. Neurochem Int 107:11–22
Nie Z, Ji XC, Wang J, Zhang HX (2017) Serum levels of 25-hydroxyvitamin D predicts infarct volume and mortality in ischemic stroke patients. J Neuroimmunol 313:41–45
Norman AW, Bouillon R, Whiting SJ, Vieth R, Lips P (2007) 13th Workshop consensus for vitamin D nutritional guidelines. J Steroid Biochem Mol Biol 103:204–205
Park KY, Chung PW, Kim YB, Moon HS, Suh BC, Won YS, Kim JM, Youn YC, Kwon OS (2015) Serum vitamin D status as a predictor of prognosis in patients with acute ischemic stroke. Cerebrovasc Dis 40:73–80
Pilz S, Tomaschitz A, Drechsler C, Zittermann A, Dekker JM, Marz W (2011) Vitamin D supplementation: a promising approach for the prevention and treatment of strokes. Curr Drug Targets 12:88–96
Poole KE, Loveridge N, Barker PJ, Halsall DJ, Rose C, Reeve J, Warburton EA (2006) Reduced vitamin D in acute stroke. Stroke 37:243–245
Qiu H, Wang M, Mi D, Zhao J, Tu W, Liu Q (2017) Vitamin D status and the risk of recurrent stroke and mortality in ischemic stroke patients: data from a 24-month follow-up study in China. J Nutr Health Aging 21:766–771
Sun Q, Pan A, Hu FB, Manson JE, Rexrode KM (2012) 25-hydroxyvitamin D levels and the risk of stroke: a prospective study and meta-analysis. Stroke 43:1470–1477
Tu WJ, Zhao SJ, Xu DJ, Chen H (2014) Serum 25-hydroxyvitamin D predicts the short-term outcomes of Chinese patients with acute ischaemic stroke. Clin Sci 126:339–346
Wajda J, Swiat M, Owczarek AJ, Brzozowska A, Olszanecka-Glinianowicz M, Chudek J (2019) Severity of vitamin D deficiency predicts mortality in ischemic stroke patients. Dis Markers 2019:3652894
Wang Q, Zhu Z, Liu Y, Tu X, He J (2018) Relationship between serum vitamin D levels and inflammatory markers in acute stroke patients. Brain Behav 8:e00885
Wang Y, Ji H, Tong Y, Zhang ZB (2014) Prognostic value of serum 25-hydroxyvitamin D in patients with stroke. Neurochem Res 39:1332–1337
Wei ZN, Kuang JG (2018) Vitamin D deficiency in relation to the poor functional outcomes in nondiabetic patients with ischemic stroke. Bioscience reports 38
Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P The Newcastle–Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 3 Aug 2019
Xu T, Zhong C, Peng Y, Chen CS, Wang J, Ju Z, Li Q, Geng D, Sun Y, Zhang D, Zhang Y, Chen J, Xu T, Zhang Y, He J (2016) Serum 25-hydroxyvitamin D deficiency predicts poor outcome amongst acute ischaemic stroke patients with low high density lipoprotein cholesterol. Eur J Neurol 23:1763–1768
Zhang B, Wang Y, Zhong Y, Liao S, Lu Z (2018) Serum 25-hydroxyvitamin D deficiency predicts poor outcome among acute ischemic stroke patients without hypertension. Neurochem Int 118:91–95
Zhou R, Wang M, Huang H, Li W, Hu Y, Wu T (2018) Lower vitamin D status is associated with an increased risk of ischemic stroke: a systematic review and meta-analysis. Nutrients 10:277
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that there are no conflicts of interest.
Rights and permissions
About this article
Cite this article
Liu, H., Wang, J. & Xu, Z. Prognostic utility of serum 25-hydroxyvitamin D in patients with stroke: a meta-analysis. J Neurol 267, 3177–3186 (2020). https://doi.org/10.1007/s00415-019-09599-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-019-09599-0